Prelude Therapeutics
PRLD
PRLD
56 hedge funds and large institutions have $150M invested in Prelude Therapeutics in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 60 → 56 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
56
Holding in Top 10
–
Calls
$4K
Puts
$4K
Top Buyers
| 1 | +$12.6M | |
| 2 | +$1.08M | |
| 3 | +$340K | |
| 4 |
Renaissance Technologies
New York
|
+$234K |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$223K |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$3.58M | |
| 3 | -$623K | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$618K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$218K |